Ernexa Therapeutics Inc (ERNA): Next-Year EPS Estimate 87.42%

As of 2026-05-14, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 87.42%. Featured in our EPS revision report on 2026-05-13.

Analyst estimates for ERNA have remained steady in the most recent observable window, with next-year EPS growth projected at 87.42%. Current-year growth stands at 83.22%.

Current Snapshot

Sector
Healthcare
Industry
Biotechnology
EPS growth next year
87.42%
EPS growth this year
83.22%
EPS next quarter (est)
N/A
Last price
$9.56

EPS Revision History

DateEPS Next YEPS This YNext Q (est)Price
2026-05-1487.42%83.22%N/A$9.56
2026-05-1387.42%83.22%N/A$13.20
2026-05-1287.42%83.22%N/A$12.01
2026-05-1187.42%83.22%N/A$7.21
2026-05-1087.42%83.22%N/A$7.53

Reports Featuring ERNA

Screen Performance

Aggregate stats across all 1666 tickers our top-EPS-revision screen has flagged over the past 43 days.

Median return since detection
+4.0%
% of tickers in the green
60%
Median return on winners
+16.0%
Large revisions captured
552

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Frequently Asked Questions

What is Ernexa Therapeutics Inc's next-year EPS growth estimate?

As of 2026-05-14, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 87.42%, based on analyst consensus.

What sector and industry does Ernexa Therapeutics Inc belong to?

Ernexa Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.

How often is this EPS estimate data updated?

EPS revision data is refreshed daily from analyst consensus estimates. ERNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Ernexa Therapeutics Inc (ERNA) appears here because it was detected by our daily top-EPS-revision-performer screen.

← All reports